{"id":"W2755607580","doi":"10.1016/s0140-6736(17)32365-6","title":"Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial","year":2017,"lang":"en","type":"article","venue":"The Lancet","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":177,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency","funders":"Eli Lilly and Company","keywords":"Docetaxel; Ramucirumab; Medicine; Internal medicine; Placebo; Metastatic Urothelial Carcinoma; Hazard ratio; Clinical endpoint; Oncology; Population; Tolerability; Discontinuation; Chemotherapy; Surgery; Clinical trial; Adverse effect; Cancer; Confidence interval; Bladder cancer; Urothelial carcinoma; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005073559,0.0006187932,0.001622489,0.0001459491,0.000341188,0.0001907562,0.0006657563,0.0001299056,0.000484634],"category_scores_gemma":[0.0001468705,0.0003365115,0.0002447048,0.0001884305,0.0003243188,0.0002796125,0.00006646494,0.000497334,0.00005790659],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003648939,"about_ca_system_score_gemma":0.001186189,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004352405,"about_ca_topic_score_gemma":0.0006064189,"domain_scores_codex":[0.9968193,0.0002131072,0.0006223003,0.000669351,0.0008465716,0.0008293715],"domain_scores_gemma":[0.9970486,0.0003098821,0.0004541031,0.001782107,0.0001670633,0.0002382076],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9854658,0.001120452,0.004098135,0.00008549346,0.0005400388,0.0002559464,0.000692087,0.0001299956,0.00001701677,0.0000101591,0.0002229083,0.007361986],"study_design_scores_gemma":[0.9801276,0.008470404,0.008130017,0.0002176213,0.0005856251,0.000007724169,0.00006315089,0.0004008016,0.0004351469,0.00002307337,0.00111175,0.0004271013],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.984304,0.0004410582,0.000220476,0.001204851,0.0007320959,0.01103215,0.0003103109,0.00008778066,0.001667274],"genre_scores_gemma":[0.994113,0.00006248167,0.0006528092,0.0009472679,0.0008963336,0.002578925,0.00009797296,0.0001076774,0.0005435035],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009809023,"threshold_uncertainty_score":0.9999087,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07605140914426525,"score_gpt":0.350020755068268,"score_spread":0.2739693459240027,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}